[Systemic manifestations associated with the use of beta-adrenolytic eyedrops (sympatholytics, beta-blockers)].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D001249:Asthma / Q000150:complications; D002318:Cardiovascular Diseases / Q000139:chemically induced; D006801:Humans; D009883:Ophthalmic Solutions; D013565:Sympatholytics / Q000009:adverse effects*
D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D013565:Sympatholytics
Manifestations générales liées à l'utilisation de collyres bêta-adrénolytiques (sympatholytiques, bêta-bloquants).